HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kuszyk, B. S. Articles by Fishman, E. K. Search for Related Content PubMed PubMed Citation Articles by Kuszyk, B. S. Articles by Fishman, E. K.

Local Tumor Recurrence Following Hepatic Cryoablation: Radiologic-histopathologic Correlation in a Rabbit Model¹

¹ From the Russell H. Morgan Department of Radiology and Radiological Science (B.S.K., D.A.B., S.S., C.A.M., K.M.H., J.E., E.K.F.), and the Departments of Pathology (J.K.B.) and Surgery (M.A.C.), the Johns Hopkins Medical Institutions, 601 N Caroline St, Baltimore, MD 21287. From the 1998 RSNA scientific assembly. Received March 10, 1999; revision requested April 23; revision received February 25, 2000; accepted March 30. Supported in part by the National Cancer Institute, grant no. CA 55641-01A1. Address correspondence to E.K.F. (e-mail: efishman@jhmi.edu).

PURPOSE: To use radiologic-histopathologic correlation in an animal model to distinguish normal postoperative findings from evidence of residual tumor after cryoablation of malignant hepatic tumors.

MATERIALS AND METHODS: Hepatic cryoablation was performed in 12 rabbits with VX2 tumors and in two healthy rabbits. Nonenhanced and dynamic contrast material–enhanced computed tomography (CT) and magnetic resonance (MR) imaging and power and color Doppler flow ultrasonography (US) were performed 7–8 days after cryoablation. Histopathologic findings were correlated with imaging findings.

RESULTS: Twenty tumors of 5–20 mm (mean, 10 mm) and seven areas of normal liver were treated with cryolesions of 11–21 mm (mean, 15 mm). All cryolesions exhibited arterial phase rim enhancement at CT and MR imaging, and 13 (57%) of 23 lesions demonstrated peripheral flow at US because of granulation tissue. There was macroscopic recurrence in 15 (75%) of 20 treated tumors; 14 (93%) appeared as peripheral nodularity with low-grade enhancement. Necrotic tissue did not enhance. Intact vessels extended up to 6 mm inside cryolesion margins and caused focal internal enhancement and Doppler flow. Areas of high signal intensity on T2-weighted MR images correlated with liquefaction necrosis, granulation tissue, and tumor.

CONCLUSION: In this animal model, recurrent tumor typically appeared as focal nodules at the cryolesion periphery. Rim and central foci of enhancement, Doppler flow, and increased signal intensity on T2-weighted MR images can be normal findings after hepatic cryoablation.

Index terms: Animals • Cryotherapy, 761.12168 • Liver, interventional procedures, 761.12168 • Liver, CT, 761.12111, 761.12113, 761.12115 • Liver, MR, 761.121411, 761.121412, 761.121415, 761.12143 • Liver, US, 761.12981, 761.12983, 761.12984 • Liver neoplasms, 761.12168

This article has been cited by other articles:

				A. L. Keppke, R. Salem, D. Reddy, J. Huang, J. Jin, A. C. Larson, and F. H. Miller Imaging of Hepatocellular Carcinoma After Treatment with Yttrium-90 Microspheres Am. J. Roentgenol., March 1, 2007; 188(3): 768 - 775. [Abstract] [Full Text] [PDF]

				T. J. Kim, W. K. Moon, J. H. Cha, J. M. Goo, K. H. Lee, K. H. Kim, J. W. Lee, J. G. Han, H.-J. Weinmann, and K. H. Chang VX2 Carcinoma in Rabbits after Radiofrequency Ablation: Comparison of MR Contrast Agents for Help in Differentiating Benign Periablational Enhancement from Residual Tumor Radiology, February 1, 2005; 234(2): 423 - 430. [Abstract] [Full Text] [PDF]

				G. S. Gazelle, P. M. McMahon, M. T. Beinfeld, E. F. Halpern, and M. C. Weinstein Metastatic Colorectal Carcinoma: Cost-effectiveness of Percutaneous Radiofrequency Ablation versus That of Hepatic Resection Radiology, December 1, 2004; 233(3): 729 - 739. [Abstract] [Full Text] [PDF]

				I. R. Kamel, D. A. Bluemke, D. Ramsey, M. Abusedera, M. Torbenson, J. Eng, G. Szarf, and J.-F. Geschwind Role of Diffusion-Weighted Imaging in Estimating Tumor Necrosis After Chemoembolization of Hepatocellular Carcinoma Am. J. Roentgenol., September 1, 2003; 181(3): 708 - 710. [Full Text] [PDF]

				B. S. Kuszyk, F. M. Corl, F. N. Franano, D. A. Bluemke, L. V. Hofmann, B. J. Fortman, and E. K. Fishman Tumor Transport Physiology: Implications for Imaging and Imaging-Guided Therapy Am. J. Roentgenol., October 1, 2001; 177(4): 747 - 753. [Full Text] [PDF]

				H. Choi, E. M. Loyer, R. A. DuBrow, H. Kaur, C. L. David, S. Huang, S. Curley, and C. Charnsangavej Radio-frequency Ablation of Liver Tumors: Assessment of Therapeutic Response and Complications RadioGraphics, October 1, 2001; 21(90001): S41 - 54. [Abstract] [Full Text] [PDF]